Molecular mechanisms of constitutive and inducible NF-kappaB activation in oesophageal adenocarcinoma

European Journal of Cancer

Volumn 51, Issue 4, 2015, Pages 464-472

  Abdel Latif, Mohamed M M ^a,b   Kelleher, Dermot ^b   Reynolds, John V ^b  

^a Assiut University   (Egypt)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Acid; adenocarcinoma; DCA; HCA; NF B; Oesophageal

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ASCORBIC ACID; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DEOXYCHOLIC ACID; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PYRROLIDINE DITHIOCARBAMATE; WORTMANNIN; ANTIOXIDANT; I KAPPA B KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CONTENT ANALYSIS; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR BIOPSY; WESTERN BLOTTING; ADENOCARCINOMA; ESOPHAGUS TUMOR; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ANTIOXIDANTS; CELL LINE, TUMOR; DEOXYCHOLIC ACID; ESOPHAGEAL NEOPLASMS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; I-KAPPA B KINASE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84924967932     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.11.014     Document Type: Article

References (43)

1. W. Blot Esophageal cancer trends and risk factors Semin Oncol 21 4 1994 403 410
2. J. McCann Esophageal cancers: changing character, increasing incidence J Natl Cancer Inst 91 6 1999 497 498
3. J. Lagergren, R. Bergström, and A. Lindgren Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma N Engl J Med 340 11 1999 825 831
4. C.P. Wild, and L.J. Hardie Reflux, Barrett's oesophagus and adenocarcinoma: burning questions Nat Rev Cancer 3 9 2003 676 684
5. P.R. Debruyne, E.A. Bruyneel, and X. Li The role of bile acids in carcinogenesis Mutat Res 480-481 2001 359 369
6. R.C. Fitzgerald, M.B. Omary, and G. Triadafilopoulos Dynamic effects of acid on Barrett's oesophagus. An ex vivo proliferation and differentiation model J Clin Invest 98 9 1996 2120 2128
7. M.M. Abdel-Latif, S. Duggan, and J.V. Reynolds Inflammation and esophageal carcinogenesis Curr Opin Pharmacol 9 4 2009 396 404
8. J.A. Jankowski, N.A. Wright, and S.J. Meltzer Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus Am J Pathol 154 4 1999 965 973
9. A.J. Jolly, C.P. Wild, and L.J. Hardie Acid and bile salts induce DNA damage in human oesophageal cell lines Mutagenesis 19 4 2004 319 324
10. A. Farhadi, J. Fields, and A. Banan Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett's esophagus, and the latter's progression toward esophageal cancer? Am J Gastroenterol 97 1 2002 22 26
11. K. Dvorak, C.M. Payne, and M. Chavarria Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus Gut 56 6 2007 763 771
12. A. Fountoulakis, I.G. Martin, and K.L. White Plasma and esophageal mucosal levels of vitamin C: role in the pathogenesis and neoplastic progression of Barrett's esophagus Dig Dis Sci 49 6 2004 914 919
13. E.B. Kopp, and S. Ghosh NF-κB and Rel proteins in innate immunity Adv Immunol 58 1995 1 27
14. P.A. Baeuerle, and T. Henkel Function and activation of NF-κB in the immune system Annu Rev Immunol 12 1994 141 179
15. M.M. Abdel-Latif, D. Kelleher, and J.V. Reynolds Potential role of NF-kappaB in esophageal adenocarcinoma: as an emerging molecular target J Surg Res 153 1 2009 172 180
16. M.M.M. Abdel-Latif, J. O'Riordan, and H.J. Windle NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy Ann Surg 239 4 2004 491 500
17. J.M. O'Riordan, M.M. Abdel-latif, and N. Ravi Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus Am J Gastroenterol 100 6 2005 1257 1264
18. G.J. Jenkins, K. Harries, and S.H. Doak The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro Carcinogenesis 25 3 2004 317 323
19. J.G. Izzo, U. Malhotra, and T.T. Wu Association of activated transcription factor nuclear factor kappaB with chemoradiation resistance and poor outcome in esophageal carcinoma J Clin Oncol 24 5 2006 748 754
20. O.H. Beahrs, D.E. Henson, and R.V.P. Hutter Oesophagus. Manual for Staging of Cancer 3rd ed. 1988 J. P. Lippincott Philadelphia 63 67
21. L. Madrigal, S. Lynch, and C. Feighery Flow cytometric analysis of surface major histocompatibility complex class II expression on human epithelial cells prepared from small intestinal biopsies J Immunol Methods 158 2 1993 207 214
22. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
23. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 5259 1970 680 685
24. L. Osborn, S. Kunkel, and G.J. Nabel Tumor necrosis factor alpha and interleukin-1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B Proc Natl Acad Sci U S A 86 7 1989 2336 2340
25. G.J. Ding, P.A. Fischer, and R.C. Boltz Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system J Biol Chem 273 44 1998 28897 28905
26. F.R. Greten, and M. Karin The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer Cancer Lett 206 2 2004 193 199
27. M.S. Hayden, and S. Ghosh Signaling to NF-kappaB Genes Dev 18 18 2004 2195 2224
28. M. Karin, and Y. Ben-Neriah Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity Annu Rev Immunol 18 2000 621 663
29. A. Jason, J.A. Gustin, and O.N. Ozes Cell type-specific expression of the IκB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-κB activation J Biol Chem 279 3 2004 1615 1620
30. S. Ghosh, and M. Karin Missing pieces in the NF-kappaB puzzle Cell 109 Suppl 2002 S81 S96
31. R. Romieu-Mourez, E. Landesman-Bollag, and D.C. Seldin Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappa Cancer Res 61 9 2001 3810 3818
32. T. Tamatani, M. Azuma, and K. Aota Enhanced IkappaB kinase activity is responsible for the augmented activity of NF-kappaB in human head and neck carcinoma cells Cancer Lett 171 2 2001 165 172
33. A.V. Gasparian, Y.J. Yao, and D. Kowalczyk The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells J Cell Sci 115 Pt 1 2002 141 151
34. L.V. Madrid, C.Y. Wang, and D.C. Guttridge Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB Mol Cell Biol 20 5 2000 1626 1638
35. L.V. Madrid, M.W. Mayo, and J.Y. Reuther Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen activated protein kinase p38 J Biol Chem 276 22 2001 18934 18940
36. N. Sizemore, S. Leung, and G.R. Stark Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit Mol Cell Biol 19 7 1999 4798 4805
37. A.B. Carter, and G.W. Hunninghake A constitutive active MEK → ERK pathway negatively regulates NF-kappa B-dependent gene expression by modulating TATA-binding protein phosphorylation J Biol Chem 275 36 2000 27858 27864
38. J. Surapisitchat, R.J. Hoefen, and X. Pi Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: Inhibitory crosstalk among MAPK family members Proc Natl Acad Sci U S A 98 11 2001 6476 6481
39. G.J. Jenkins, F.R. D'Souza, and S.H. Suzen Deoxycholic acid at neutral and acid pH, is genotoxic to oesophageal cells through the induction of ROS: the potential role of anti-oxidants in Barrett's oesophagus Carcinogenesis 28 1 2007 136 142
40. J.R. Olliver, L.J. Hardie, and S. Dexter DNA damage levels are raised in Barrett's oesophageal mucosa relative to the squamous epithelium of the oesophagus Biomarkers 8 6 2003 509 521
41. G.J. Wetscher, P.R. Hinder, and D. Bagchi Free radical scavengers prevent reflux esophagitis in rats Dig Dis Sci 40 6 1995 1292 1296
42. T.Y. Oh, J.S. Lee, and B.O. Ahn Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats Gut 49 3 2001 364 371
43. T.Y. Oh, J.S. Lee, and B.O. Ahn Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment Free Radic Biol Med 30 8 2001 905 915